Back

Novel ACE2 PET imaging with 68Ga-cyc-DX600: a translational advancement for early detection and monitoring in heart failure and myocarditis

29 August 2025 (07:00 - 18:00)
Organised by: Logo
Congress Presentation Part of: Research highlights in nuclear cardiology Molecular Imaging ESC Professional Premium Access ESC Congress 2025 European Society of Cardiology

About the speaker

Photo
Doctor Cong Wang

Zhongshan Hospital Fudan University, Shanghai (China)

5 More presentations in this session

Presentation thumbnail
Visualisation and diagnostic utility for cardiovascular diseases using Biparametric Heatmap in iodine-123-beta-methyl-p-iodophenyl-pentadecanoic acid scintigraphy
Doctor H. Miyauchi (Chiba, JP)
Abstract Slides Video
Presentation thumbnail
Diagnostic value of relative flow reserve in patients with prior coronary artery disease: a post-hoc analysis of the PACIFIC-2 trial
Mr R. Hoek (Amsterdam, NL)
Abstract Slides Video
Presentation thumbnail
Temporal trends of normal scan results and pretest probability in myocardial perfusion imaging in a tertiary referral center in Switzerland between 2000 and 2023
Doctor S. Frey (Basel, CH)
Abstract Slides Video
Presentation thumbnail
Quantitative SPECT/CT for diagnosis of transthyretin amyloid cardiomyopathy: a pathology-based study
Doctor G. Tersalvi (Rochester, US)
Abstract Slides Video
Presentation thumbnail
Novel DPP4-targeted PET probe for non-invasive imaging of inflammatory heart in viral myocarditis
Professor X. Rao (Wuhan, CN)
Abstract Slides Video

Access the full session

Session thumbnail
Research highlights in nuclear cardiology
Video

The Event

Event poster

ESC Congress 2025

29 August - 1 September 2025
You may be interested in
thumbnail
Congress Presentation
Novel DPP4-targeted PET probe for non-invasive imaging of inflammatory heart in viral myocarditis
thumbnail
Congress Presentation
Circulating ACE2 and the association of endothelial progenitor cell in CAD patients
thumbnail
Congress Presentation
Comprehensive analysis of desmosomal proteins remodeling identifies DSC2 as a potential biomarker for arrhythmogenic cardiomyopathy

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources